Concepedia

Yoshifumi Sasaki

YS

Statistics

Publications

5

Citations

507

H-Index

5

Active since

1995

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Yoshifumi Sasaki is an author at Mitsubishi Tanabe Pharma Corporation specializing in medicine, organic synthesis, and aromatic hydroxylation.

Publications per year

1995–2019

5

Publications

5

Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures

Yuichi Yokoyama, Yoshifumi Sasaki, Natsuko Terasaki et al. · Biological and Pharmaceutical Bulletin · 2018 · 157 citations · Full text

Pharmacy, Pharmacology, Toxicology +15

Attractin/Mahogany/Zitter plays a critical role in myelination of the central nervous system

Takashi Kuramoto, Kazuhiro Kitada, Toshihide Inui et al. · Proceedings of the National Academy of Sciences · 2001 · 136 citations

Life Sciences, Genetics, Neuroscience +15

Direct synthesis of phenol by hydroxylation of benzene with oxygen and hydrogen

Takanori Miyake, Michiyuki Hamada, Yoshifumi Sasaki et al. · Applied Catalysis A General · 1995 · 105 citations

Natural Sciences, Chemical Engineering, Chemistry +7

Distribution of Inflammatory Cells in Adventitia Changed with Advancing Atherosclerosis of Human Coronary Artery

Makoto Watanabe, Akiko Sangawa, Yoshifumi Sasaki et al. · Journal of Atherosclerosis and Thrombosis · 2007 · 79 citations · Full text

Medicine, Cardiology, Pathology +16

Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease

Masaru Miura, Tohru Kobayashi, Toru Igarashi et al. · The Pediatric Infectious Disease Journal · 2019 · 30 citations

Medicine, Pediatrics, Pharmacotherapy +14

1–5 of 5